Evidence map›Paper›PMID 36053916›Full record

ArticleAnnals of neurology2022

External Validation of e-ASPECTS Software for Interpreting Brain CT in Stroke.

Grant Mair, Philip White, Philip M Bath, Keith W Muir, Rustam Al-Shahi Salman, Chloe Martin, David Dye, Francesca M Chappell, Adam Vacek, Rüdiger von Kummer and 3 more

Abstract read
In one paragraph

Article in Annals of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Real-world evaluation of Brainomix e-Stroke software.Stroke and vascular neurology · 2024
    Article
  15. Article
  16. Article
  17. Accuracy of artificial intelligence software for CT angiography in stroke.Annals of clinical and translational neurology · 2023
    Article
  18. What's the Future of Vascular Neurology?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Grant MairCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0003-2189-443X
Philip WhiteTranslational and Clinical Research Institute, Newcastle University and Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
Philip M BathStroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, UK.ORCID 0000-0003-2734-5132
Keith W MuirSchool of Psychology & Neuroscience, University of Glasgow, Glasgow, UK.ORCID 0000-0001-9535-022X
Rustam Al-Shahi SalmanCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-2108-9222
Chloe MartinCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
David DyeCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-6171-614X
Francesca M ChappellCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-7742-1757
Adam VacekCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-4420-7404
Rüdiger von KummerDepartment of Neuroradiology, University Hospital, Technische Universität Dresden, Dresden, Germany.ORCID 0000-0003-0119-4604
Malcolm MacleodCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-9187-9839
Nikola SpriggTranslational and Clinical Research Institute, Newcastle University and Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.ORCID 0000-0002-5871-8168
Joanna M WardlawCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0002-9812-6642

Funding

British Heart Foundation CS/18/2/33719British Heart Foundation FS/13/72/30531British Heart Foundation SP/12/2/29422Chief Scientist Office CZG/2/265Medical Research Council G0300623Medical Research Council G0400069Medical Research Council G1002605Medical Research Council G108/613Medical Research Council MC_G1002455Medical Research Council MC_PC_17188
6 · The paper itself

Abstract

objectiveThe purpose of this study was to test e-ASPECTS software in patients with stroke. Marketed as a decision-support tool, e-ASPECTS may detect features of ischemia or hemorrhage on computed tomography (CT) imaging and quantify ischemic extent using Alberta Stroke Program Early CT Score (ASPECTS).

methodsUsing CT from 9 stroke studies, we compared software with masked experts. As per indications for software use, we assessed e-ASPECTS results for patients with/without middle cerebral artery (MCA) ischemia but no other cause of stroke. In an analysis outside the intended use of the software, we enriched our dataset with non-MCA ischemia, hemorrhage, and mimics to simulate a representative "front door" hospital population. With final diagnosis as the reference standard, we tested the diagnostic accuracy of e-ASPECTS for identifying stroke features (ischemia, hyperattenuated arteries, and hemorrhage) in the representative population.

resultsWe included 4,100 patients (51% women, median age = 78 years, National Institutes of Health Stroke Scale [NIHSS] = 10, onset to scan = 2.5 hours). Final diagnosis was ischemia (78%), hemorrhage (14%), or mimic (8%). From 3,035 CTs with expert-rated ASPECTS, most (2084/3035, 69%) e-ASPECTS results were within one point of experts. In the representative population, the diagnostic accuracy of e-ASPECTS was 71% (95% confidence interval [CI] = 70-72%) for detecting ischemic features, 85% (83-86%) for hemorrhage. Software identified more false positive ischemia (12% vs 2%) and hemorrhage (14% vs <1%) than experts.

interpretationOn independent testing, e-ASPECTS provided moderate agreement with experts and overcalled stroke features. Therefore, future prospective trials testing impacts of artificial intelligence (AI) software on patient care and outcome are required before widespread implementation of stroke decision-support software. ANN NEUROL 2022;92:943-957.

Indexed as

Brain IschemiaStrokeAgedArtificial IntelligenceBrainFemaleHumansMaleRetrospective StudiesSoftwareTomography, X-Ray Computed

Identifiers

PMID36053916
PMCPMC9826303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.